PharVision Advisers’s Rambus RMBS Stock Holding History

PharVision Advisers’s Portfolio RMBS Stock Details RMBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,778	Closed	-$253K	–	475
2024 Q4	$253K	Buy	+4,778	New	+$244K	0.21%	217

Other funds holding RMBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PharVision Advisers's RMBS Position: Q1 2025 in Review

PharVision Advisers sold out of Rambus (RMBS) in Q1 2025, closing a stake of 4,778 shares — an estimated $253K sold.

PharVision Advisers first reported a position in RMBS in Q4 2024 and held it in 1 quarter. The position peaked at $253K in Q4 2024. 414 funds tracked by Wall St. Rank hold RMBS as of Q1 2025.

PharVision Advisers reported no remaining Rambus position as of Q1 2025 after selling out during the quarter.
PharVision Advisers sold 4,778 Rambus shares in Q1 2025, an estimated $253K.
PharVision Advisers first reported a position in Rambus in Q4 2024 and held it in 1 quarter.
PharVision Advisers's Rambus position peaked at $253K in Q4 2024.
414 funds tracked by Wall St. Rank held Rambus as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.